Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNatureNobel
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
2011
Stem Cell–Derived Culture Models of Hepatitis E Virus Infection
2018 StandoutNobel
ISG15: leading a double life as a secreted molecule
2013
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Immune Response in Hepatitis B Virus Infection
2015
Control of cccDNA function in hepatitis B virus infection
2009
Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies
2016 StandoutNobel
Toll-like receptors as targets in chronic liver diseases
2009
Mechanisms of hepatic stellate cell activation
2017 Standout
Hepatitis B Virus Polymerase Blocks Pattern Recognition Receptor Signaling via Interaction with DDX3: Implications for Immune Evasion
2010
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection
2016
The multidimensional mechanisms of long noncoding RNA function
2017 Standout
New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus
2016
The Impact of IL28B Genetic Variants on Recurrent Hepatitis C in Liver Transplantation: Significant Lessons from a Dual Graft Case
2011
Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals
2011
New insight in the pathobiology of hepatitis B virus infection
2012
Toll-like receptors and cancer
2008
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
2018 Standout
Differential Expression of Toll-Like Receptors in Patients With Irritable Bowel Syndrome
2010
Hepatocellular carcinoma
2021 Standout
An Efficient Antiviral Strategy for Targeting Hepatitis B Virus Genome Using Transcription Activator-Like Effector Nucleases
2013
Interaction between microbiota and immunity in health and disease
2020 Standout
Hepatitis C virus and microRNAs: miRed in a host of possibilities
2014
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice
2012
Clinical cancer nanomedicine
2019
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Inflammation and Colon Cancer
2010 Standout
Long noncoding RNAs in viral infections
2015
Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity
2019
Insights from nanomedicine into chloroquine efficacy against COVID-19
2020 Standout
Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
2020
Gut Bacteria Drive Kupffer Cell Expansion via MAMP-Mediated ICAM-1 Induction on Sinusoidal Endothelium and Influence Preservation-Reperfusion Injury after Orthotopic Liver Transplantation
2012
Role of Kupffer cells in pathogenesis of sepsis‐induced drug metabolizing dysfunction
2011
To translate, or not to translate: viral and host mRNA regulation by interferon-stimulated genes
2015 StandoutNobel
Living in the liver: hepatic infections
2012
Immunity, Inflammation, and Cancer
2010 Standout
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
The Natural Course of Chronic Hepatitis B Virus Infection and Its Management
2013
Inverse association of IL28B genotype and liver mRNA expression of genes promoting or suppressing antiviral state
2011
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism
2017 StandoutNobel
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Role of toll-like receptors in tissue repair and tumorigenesis
2008
Interferon-stimulated genes and their role in controlling hepatitis C virus
2013
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNobel
Innate and adaptive immune responses in HCV infections
2014
Hepatitis B virus infection
2018
Lipid nanoparticles for nucleic acid delivery: Current perspectives
2020
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Immunomodulation by endothelial cells — partnering up with the immune system?
2022
Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration
2013
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Hepatitis C Virus Infection Induces Autocrine Interferon Signaling by Human Liver Endothelial Cells and Release of Exosomes, Which Inhibits Viral Replication
2014
The role of innate immunity in the immunopathology and treatment of HBV infection
2016
Host – hepatitis C viral interactions: The role of genetics
2016
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
The immunology of hepatocellular carcinoma
2018
Design of therapeutic vaccines: hepatitis B as an example
2011
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Immune surveillance by the liver
2013
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
The Antiviral Activities of ISG15
2013
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
2013
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
Hepatitis C Virus Reveals a Novel Early Control in Acute Immune Response
2011
Toll-Like Receptor Signaling Pathways
2014 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection
2014
Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells
2016 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development
2021 StandoutNobel
Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery
2022 StandoutNobel
Hepatocellular Carcinoma
2019 Standout
Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individuals
2017
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
2015 StandoutNobel
Polymorphisms in melanoma differentiation‐associated gene 5 link protein function to clearance of hepatitis C virus
2014 StandoutNobel
An Evolutionary Perspective of Nutrition and Inflammation as Mechanisms of Cardiovascular Disease
2015
The Hepatitis B Virus X Protein Disrupts Innate Immunity by Downregulating Mitochondrial Antiviral Signaling Protein
2010
Quantitative Proteomics Identifies Host Factors Modulated during Acute Hepatitis E Virus Infection in the Swine Model
2014
ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication
2017
Kupffer Cell Metabolism and Function.
2015
2014
New Insights into how HBV Manipulates the Innate Immune Response to Establish Acute and Persistent Infection
2013
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Republished: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
2013
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation
2016 StandoutNobel
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
First international external quality assessment for hepatitis delta virus RNA quantification in plasma
2016
A Genetic Interaction between the Core and NS3 Proteins of Hepatitis C Virus Is Essential for Production of Infectious Virus
2011
Selective activation of Toll-like receptor 7 in activated hepatic stellate cells may modulate their profibrogenic phenotype
2012
Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKϵ and DDX3
2010
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Melanoma Differentiation–Associated Gene 5 Senses Hepatitis B Virus and Activates Innate Immune Signaling To Suppress Virus Replication
2013
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Emerging concepts in immunity to hepatitis C virus infection
2013
New Methods in Tissue Engineering: Improved Models for Viral Infection
2014 StandoutNobel
New Therapeutic Targets and Drugs for the Treatment of Chronic Hepatitis B
2013
Works of Ruth Broering being referenced
Hepatitis B virus suppresses toll-like receptor–mediated innate immune responses in murine parenchymal and nonparenchymal liver cells #
2008
Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection
2015
Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication
2008
Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice
2007
Toll‐like receptor‐induced innate immune responses in non‐parenchymal liver cells are cell type‐specific
2009
Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections
2012
Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication
2009
The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response
2010
KIR2DL3+NKG2A− natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs
2014
Role of Toll-like receptor 2 in the immune response against hepadnaviral infection
2012
Toll‐like receptor‐mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen
2014
MicroRNA ‐155 controls T oll‐like receptor 3‐ and hepatitis C virus‐induced immune responses in the liver
2013
Identification of proteins that mediate the pro-viral functions of the interferon stimulated gene 15 in hepatitis C virus replication
2013
Role of Toll-like receptors in liver health and disease
2011
Chemical modifications on siRNAs avoid Toll-like-receptor-mediated activation of the hepatic immune system in vivo and in vitro
2013
TLR2 Stimulation Strengthens Intrahepatic Myeloid-Derived Cell-Mediated T Cell Tolerance through Inducing Kupffer Cell Expansion and IL-10 Production
2018